{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:55:30Z","timestamp":1789152930943,"version":"build-2803163510"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847912"],"award-info":[{"award-number":["847912"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73617-9","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:07:07Z","timestamp":1779725227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-7916","authenticated-orcid":false,"given":"Youness","family":"Azimzade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-2594","authenticated-orcid":false,"given":"Mads Haugland","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5012-7438","authenticated-orcid":false,"given":"Vessela Nedelcheva","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Frigessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"K\u00f6hn-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"73617_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen, M. et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17\u201332 (2004).","journal-title":"Cancer Cell"},{"key":"73617_CR2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293\u20131308 (2018).","journal-title":"Cell"},{"key":"73617_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","volume":"578","author":"HW Jackson","year":"2020","unstructured":"Jackson, H. W. et al. The single-cell pathology landscape of breast cancer. Nature 578, 615\u2013620 (2020).","journal-title":"Nature"},{"key":"73617_CR4","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"73617_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.14348\/molcells.2023.2178","volume":"46","author":"Y Im","year":"2023","unstructured":"Im, Y. & Kim, Y. A comprehensive overview of RNA deconvolution methods and their application. Mol. Cells 46, 99 (2023).","journal-title":"Mol. Cells"},{"key":"73617_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1158\/1078-0432.CCR-21-1442","volume":"28","author":"L Kester","year":"2022","unstructured":"Kester, L. et al. Differential survival and therapy benefit of patients with breast cancer are characterized by distinct epithelial and immune cell microenvironments. Clin. Cancer Res. 28, 960\u2013971 (2022).","journal-title":"Clin. Cancer Res."},{"key":"73617_CR7","doi-asserted-by":"crossref","unstructured":"Azimzade, Y. et al. Explainable machine learning reveals the role of the breast tumor microenvironment in neoadjuvant chemotherapy outcome. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2023.09.07.556655v1 (2023).","DOI":"10.1101\/2023.09.07.556655"},{"key":"73617_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","volume":"18","author":"V Marx","year":"2021","unstructured":"Marx, V. Method of the year: spatially resolved transcriptomics. Nat. Methods 18, 9\u201314 (2021).","journal-title":"Nat. Methods"},{"key":"73617_CR9","doi-asserted-by":"crossref","unstructured":"Ali, H. R. & West, R. B. Spatial biology of breast cancer. Cold Spring Harb. Perspect. Med. 14, 5 (2024).","DOI":"10.1101\/cshperspect.a041335"},{"key":"73617_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s43018-020-0026-6","volume":"1","author":"HR Ali","year":"2020","unstructured":"Ali, H. R. et al. Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer. Nat. Cancer 1, 163\u2013175 (2020).","journal-title":"Nat. Cancer"},{"key":"73617_CR11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41586-023-06498-3","volume":"621","author":"XQ Wang","year":"2023","unstructured":"Wang, X. Q. et al. Spatial predictors of immunotherapy response in triple-negative breast cancer. Nature 621, 868\u2013876 (2023).","journal-title":"Nature"},{"key":"73617_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35238-w","volume":"14","author":"S Tietscher","year":"2023","unstructured":"Tietscher, S. et al. A comprehensive single-cell map of t cell exhaustion-associated immune environments in human breast cancer. Nat. Commun. 14, 98 (2023).","journal-title":"Nat. Commun."},{"key":"73617_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1214\/08-AOAS169","volume":"2","author":"H Ishwaran","year":"2008","unstructured":"Ishwaran, H., Kogalur, U. B., Blackstone, E. H. & Lauer, M. S. Random survival forests. Ann. Appl. Stat. 2, 841\u2013860 (2008).","journal-title":"Ann. Appl. Stat."},{"key":"73617_CR14","unstructured":"Van Belle, V., Pelckmans, K., Suykens, J. A. & Van Huffel, S. Survival SVM: a practical scalable algorithm. In Proc. 16th European Symposium on Artificial Neural Networks (ESANN 2008), (ed. Verleysen, M.) pp. 89\u201394 (d-side publ., Evere, Belgium, 2008)."},{"key":"73617_CR15","doi-asserted-by":"crossref","unstructured":"Friedman, J. H. Greedy function approximation: a gradient boosting machine. Ann. Stat. 29, 5 (2001).","DOI":"10.1214\/aos\/1013203451"},{"key":"73617_CR16","unstructured":"Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. 30, 4765\u20134774 (2017)."},{"key":"73617_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks, A. G. & Winer, E. P. Breast cancer treatment: a review. Jama 321, 288\u2013300 (2019).","journal-title":"Jama"},{"key":"73617_CR18","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda, E., Anchondo-Nu\u00f1ez, P., Acu\u00f1a-Aguilar, L. E., G\u00f3mez-Valles, F. O. & Ram\u00edrez-Valdespino, C. A. Subtypes of breast cancer. In Breast Cancer (ed. Mayrovitz, H. N.) pp. 31-42 (Exon Publications, 2022).","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"key":"73617_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"73617_CR20","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1\/m-2 macrophages and the Th1\/Th2 paradigm. J. Immunol. 164, 6166\u20136173 (2000).","journal-title":"J. Immunol."},{"key":"73617_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723\u2013737 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"73617_CR22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160 (2009).","journal-title":"J. Clin. Oncol."},{"key":"73617_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41588-022-01041-y","volume":"54","author":"E Danenberg","year":"2022","unstructured":"Danenberg, E. et al. Breast tumor microenvironment structures are associated with genomic features and clinical outcome. Nat. Genet. 54, 660\u2013669 (2022).","journal-title":"Nat. Genet."},{"key":"73617_CR24","doi-asserted-by":"publisher","first-page":"786429","DOI":"10.3389\/fimmu.2021.786429","volume":"12","author":"X Ma","year":"2022","unstructured":"Ma, X. et al. Spatial distribution and predictive significance of dendritic cells and macrophages in esophageal cancer treated with combined chemoradiotherapy and PD-1 blockade. Front. Immunol. 12, 786429 (2022).","journal-title":"Front. Immunol."},{"key":"73617_CR25","doi-asserted-by":"publisher","first-page":"062415","DOI":"10.1103\/PhysRevE.96.062415","volume":"96","author":"Y Azimzade","year":"2017","unstructured":"Azimzade, Y. & Mashaghi, A. Search efficiency of biased migration towards stationary or moving targets in heterogeneously structured environments. Phys. Rev. E 96, 062415 (2017).","journal-title":"Phys. Rev. E"},{"key":"73617_CR26","unstructured":"Azimzade, Y. Dynamics of motile populations in heterogeneous environments. Preprint at https:\/\/arxiv.org\/abs\/1710.07937 (2017)."},{"key":"73617_CR27","unstructured":"Fox, J. & Weisberg, S. Cox proportional-hazards regression for survival data. In An R and S-PLUS Companion to Applied Regression, Vol. 2002 (SAGE Publications, 2002)."},{"key":"73617_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/EDE.0000000000001630","volume":"34","author":"R Denz","year":"2023","unstructured":"Denz, R. & Timmesfeld, N. Visualizing the (causal) effect of a continuous variable on a time-to-event outcome. Epidemiology 34, 652\u2013660 (2023).","journal-title":"Epidemiology"},{"key":"73617_CR29","doi-asserted-by":"crossref","unstructured":"Ma, R.-Y., Black, A. & Qian, B.-Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol.43, 546\u2013563 (2022).","DOI":"10.1016\/j.it.2022.04.008"},{"key":"73617_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","volume":"15","author":"Y Tie","year":"2022","unstructured":"Tie, Y., Tang, F., Wei, Y. -q & Wei, X. -w Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J. Hematol. Oncol. 15, 61 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"73617_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-020-05771-7","volume":"183","author":"C Criscitiello","year":"2020","unstructured":"Criscitiello, C. et al. Tumor-infiltrating lymphocytes (TILs) in er+\/her2- breast cancer. Breast Cancer Res. Treat. 183, 347\u2013354 (2020).","journal-title":"Breast Cancer Res. Treat."},{"key":"73617_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez, A. et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat. Med. 27, 820\u2013832 (2021).","journal-title":"Nat. Med."},{"key":"73617_CR33","doi-asserted-by":"publisher","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-023-01767-y (2023).","DOI":"10.1038\/s41587-023-01767-y"},{"key":"73617_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys, R., Saelens, W. & Saeys, Y. Nichenet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159\u2013162 (2020).","journal-title":"Nat. Methods"},{"key":"73617_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten, K. et al. Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer. Cancer Cell 40, 624\u2013638 (2022).","journal-title":"Cancer Cell"},{"key":"73617_CR36","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/bioinformatics\/btm305","volume":"23","author":"HM B\u00f8velstad","year":"2007","unstructured":"B\u00f8velstad, H. M. et al. Predicting survival from microarray data-a comparative study. Bioinformatics 23, 2080\u20132087 (2007).","journal-title":"Bioinformatics"},{"key":"73617_CR37","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajpath.2017.04.022","volume":"187","author":"HG Russnes","year":"2017","unstructured":"Russnes, H. G., Lingj\u00e6rde, O. C., B\u00f8rresen-Dale, A.-L. & Caldas, C. Breast cancer molecular stratification: from intrinsic subtypes to integrative clusters. Am. J. Pathol. 187, 2152\u20132162 (2017).","journal-title":"Am. J. Pathol."},{"key":"73617_CR38","doi-asserted-by":"crossref","unstructured":"Swarbrick, A., Fernandez-Martinez, A. & Perou, C. M. Gene-expression profiling to decipher breast cancer inter-and intratumor heterogeneity. Cold Spring Harb. Perspect. Med. 14, 5 (2024).","DOI":"10.1101\/cshperspect.a041320"},{"key":"73617_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fimmu.2018.00367","volume":"9","author":"D Krijgsman","year":"2018","unstructured":"Krijgsman, D., Hokland, M. & Kuppen, P. J. The role of natural killer T cells in cancer a phenotypical and functional approach. Front. Immunol. 9, 367 (2018).","journal-title":"Front. Immunol."},{"key":"73617_CR40","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.3390\/ijms24032743","volume":"24","author":"J-S Almeida","year":"2023","unstructured":"Almeida, J.-S. et al. Natural killer T-like cells: immunobiology and role in disease. Int. J. Mol. Sci. 24, 2743 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"73617_CR41","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","volume":"25","author":"H Ali","year":"2014","unstructured":"Ali, H. et al. Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients. Ann. Oncol. 25, 1536\u20131543 (2014).","journal-title":"Ann. Oncol."},{"key":"73617_CR42","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1158\/0008-5472.CAN-11-3468","volume":"72","author":"V Sisirak","year":"2012","unstructured":"Sisirak, V. et al. Impaired IFN-\u03b1 production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res. 72, 5188\u20135197 (2012).","journal-title":"Cancer Res."},{"key":"73617_CR43","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.21873\/invivo.11415","volume":"32","author":"H Lee","year":"2018","unstructured":"Lee, H. et al. Cd11c-positive dendritic cells in triple-negative breast cancer. Vivo 32, 1561\u20131569 (2018).","journal-title":"Vivo"},{"key":"73617_CR44","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1158\/1078-0432.CCR-04-0684","volume":"10","author":"I Treilleux","year":"2004","unstructured":"Treilleux, I. et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 10, 7466\u20137474 (2004).","journal-title":"Clin. Cancer Res."},{"key":"73617_CR45","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3390\/diagnostics11040702","volume":"11","author":"J Szpor","year":"2021","unstructured":"Szpor, J. et al. Dendritic cells are associated with prognosis and survival in breast cancer. Diagnostics 11, 702 (2021).","journal-title":"Diagnostics"},{"key":"73617_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/cancers13030373","volume":"13","author":"T Accogli","year":"2021","unstructured":"Accogli, T., Bruchard, M. & V\u00e9gran, F. Modulation of cd4 t cell response according to tumor cytokine microenvironment. Cancers 13, 373 (2021).","journal-title":"Cancers"},{"key":"73617_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48300-4","volume":"13","author":"CA Huertas-Caro","year":"2023","unstructured":"Huertas-Caro, C. A. et al. Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer. Sci. Rep. 13, 21324 (2023).","journal-title":"Sci. Rep."},{"key":"73617_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-016-3743-x","volume":"156","author":"H Matsumoto","year":"2016","unstructured":"Matsumoto, H. et al. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res. Treat. 156, 237\u2013247 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"73617_CR49","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/imr.12976","volume":"302","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. & Swarbrick, A. Single-cell advances in stromal-leukocyte interactions in cancer. Immunol. Rev. 302, 286\u2013298 (2021).","journal-title":"Immunol. Rev."},{"key":"73617_CR50","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1371\/journal.pgen.0030164","volume":"3","author":"J-T Chi","year":"2007","unstructured":"Chi, J.-T. et al. Gene expression programs of human smooth muscle cells: tissue-specific differentiation and prognostic significance in breast cancers. PLoS Genet. 3, e164 (2007).","journal-title":"PLoS Genet."},{"key":"73617_CR51","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3892\/mco.2015.526","volume":"3","author":"FGL Mundim","year":"2015","unstructured":"Mundim, F. G. L. et al. Myc is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Mol. Clin. Oncol. 3, 506\u2013514 (2015).","journal-title":"Mol. Clin. Oncol."},{"key":"73617_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13329-5","volume":"10","author":"X Tekpli","year":"2019","unstructured":"Tekpli, X. et al. An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. Nat. Commun. 10, 5499 (2019).","journal-title":"Nat. Commun."},{"key":"73617_CR53","doi-asserted-by":"publisher","first-page":"e108647","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz, S., Schuhwerk, H., Brabletz, T. & Stemmler, M. P. Dynamic emt: a multi-tool for tumor progression. EMBO J. 40, e108647 (2021).","journal-title":"EMBO J."},{"key":"73617_CR54","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00018-011-0862-8","volume":"69","author":"A Silini","year":"2012","unstructured":"Silini, A. et al. Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor\u2019s proangiogenic microenvironment. Cell. Mol. Life Sci. 69, 1167\u20131178 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"73617_CR55","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.3892\/or.2015.3917","volume":"33","author":"Z Xu","year":"2015","unstructured":"Xu, Z. et al. Overexpression of the regulator of G-protein signaling 5 reduces the survival rate and enhances the radiation response of human lung cancer cells. Oncol. Rep. 33, 2899\u20132907 (2015).","journal-title":"Oncol. Rep."},{"key":"73617_CR56","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/cancers13061477","volume":"13","author":"M Oshi","year":"2021","unstructured":"Oshi, M. et al. Abundance of microvascular endothelial cells is associated with response to chemotherapy and prognosis in colorectal cancer. Cancers 13, 1477 (2021).","journal-title":"Cancers"},{"key":"73617_CR57","doi-asserted-by":"publisher","first-page":"583572","DOI":"10.3389\/fcell.2021.583572","volume":"9","author":"X Wan","year":"2021","unstructured":"Wan, X. et al. Estrogen receptor \u03b1 mediates doxorubicin sensitivity in breast cancer cells by regulating E-cadherin. Front. Cell Dev. Biol. 9, 583572 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"73617_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1200\/OP.21.00384","volume":"18","author":"NP McAndrew","year":"2022","unstructured":"McAndrew, N. P. & Finn, R. S. Clinical review on the management of hormone receptor\u2013positive metastatic breast cancer. JCO Oncol. Pract. 18, 319\u2013327 (2022).","journal-title":"JCO Oncol. Pract."},{"key":"73617_CR59","doi-asserted-by":"publisher","first-page":"e1002194","DOI":"10.1371\/journal.pmed.1002194","volume":"13","author":"HR Ali","year":"2016","unstructured":"Ali, H. R., Chlon, L., Pharoah, P. D., Markowetz, F. & Caldas, C. Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study. PLoS Med. 13, e1002194 (2016).","journal-title":"PLoS Med."},{"key":"73617_CR60","doi-asserted-by":"publisher","first-page":"1441820","DOI":"10.3389\/fimmu.2024.1441820","volume":"15","author":"M Stavrou","year":"2024","unstructured":"Stavrou, M. & Constantinidou, A. Tumor associated macrophages in breast cancer progression: implications and clinical relevance. Front. Immunol. 15, 1441820 (2024).","journal-title":"Front. Immunol."},{"key":"73617_CR61","unstructured":"Zhao, J. et al. Immune microenvironment and intrinsic subtyping in hormone receptor-positive\/HER2-negative breast cancer. Breast Cancer Res. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7881184\/ (2021)."},{"key":"73617_CR62","unstructured":"Buisseret, L. et al. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status. Breast Cancer Res. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6611750\/ (2019)."},{"key":"73617_CR63","first-page":"749120","volume":"11","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. Research progress on the role of regulatory T cell in tumor microenvironment in the treatment of breast cancer. Front. Oncol. 11, 749120 (2021).","journal-title":"Front. Oncol."},{"key":"73617_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40487-022-00214-3","volume":"11","author":"E Allison","year":"2023","unstructured":"Allison, E., Edirimanne, S., Matthews, J. & Fuller, S. J. Breast cancer survival outcomes and tumor-associated macrophage markers: a systematic review and meta-analysis. Oncol. Ther. 11, 27\u201348 (2023).","journal-title":"Oncol. Ther."},{"key":"73617_CR65","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s43018-023-00527-w","volume":"4","author":"S Onkar","year":"2023","unstructured":"Onkar, S. et al. Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment. Nat. Cancer 4, 516\u2013534 (2023).","journal-title":"Nat. Cancer"},{"key":"73617_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11788-4","volume":"10","author":"Y-K Huang","year":"2019","unstructured":"Huang, Y.-K. et al. Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry. Nat. Commun. 10, 3928 (2019).","journal-title":"Nat. Commun."},{"key":"73617_CR67","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1158\/0008-5472.CAN-18-1367","volume":"78","author":"M Yang","year":"2018","unstructured":"Yang, M., McKay, D., Pollard, J. W. & Lewis, C. E. Diverse functions of macrophages in different tumor microenvironments. Cancer Res. 78, 5492\u20135503 (2018).","journal-title":"Cancer Res."},{"key":"73617_CR68","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","volume":"44","author":"I Nasir","year":"2023","unstructured":"Nasir, I. et al. Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies. Trends Immunol. 44, 971\u2013985 (2023).","journal-title":"Trends Immunol."},{"key":"73617_CR69","doi-asserted-by":"publisher","unstructured":"Matusiak, M. et al. A spatial map of human macrophage niches reveals context-dependent macrophage functions in colon and breast cancer. Res. Square. Preprint at https:\/\/doi.org\/10.21203\/rs.3.rs-2393443\/v1 (2023).","DOI":"10.21203\/rs.3.rs-2393443\/v1"},{"key":"73617_CR70","doi-asserted-by":"publisher","first-page":"979116","DOI":"10.3389\/fimmu.2022.979116","volume":"13","author":"L Fang","year":"2022","unstructured":"Fang, L. et al. Tumor accomplice: T cell exhaustion induced by chronic inflammation. Front. Immunol. 13, 979116 (2022).","journal-title":"Front. Immunol."},{"key":"73617_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00549-7","volume":"12","author":"Y Qian","year":"2024","unstructured":"Qian, Y., Yin, Y., Zheng, X., Liu, Z. & Wang, X. Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities. Biomark. Res. 12, 1 (2024).","journal-title":"Biomark. Res."},{"key":"73617_CR72","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cell.2019.03.005","volume":"177","author":"J Wagner","year":"2019","unstructured":"Wagner, J. et al. A single-cell atlas of the tumor and immune ecosystem of human breast cancer. Cell 177, 1330\u20131345 (2019).","journal-title":"Cell"},{"key":"73617_CR73","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","volume":"55","author":"BG Nixon","year":"2022","unstructured":"Nixon, B. G. et al. Tumor-associated macrophages expressing the transcription factor Irf8 promote T cell exhaustion in cancer. Immunity 55, 2044\u20132058 (2022).","journal-title":"Immunity"},{"key":"73617_CR74","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill, R. et al. Cxcl9: Spp1 macrophage polarity identifies a network of cellular programs that control human cancers. Science 381, 515\u2013524 (2023).","journal-title":"Science"},{"key":"73617_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-016-1035-9","volume":"18","author":"T Matsumoto","year":"2016","unstructured":"Matsumoto, T. et al. Soluble siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264. 7 macrophages. Arthritis Res. Ther. 18, 1\u201313 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"73617_CR76","doi-asserted-by":"crossref","unstructured":"Schmassmann, P. et al. Targeting the Siglec\u2013sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma. Sci Transl Med. 15, 705:eadf5302 (2023).","DOI":"10.1126\/scitranslmed.adf5302"},{"key":"73617_CR77","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y Mei","year":"2023","unstructured":"Mei, Y. et al. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat. Cancer 4, 1273\u20131291 (2023).","journal-title":"Nat. Cancer"},{"key":"73617_CR78","doi-asserted-by":"publisher","first-page":"1178817","DOI":"10.3389\/fimmu.2023.1178817","volume":"14","author":"M Lustig","year":"2023","unstructured":"Lustig, M. et al. Disruption of the sialic acid\/siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells. Front. Immunol. 14, 1178817 (2023).","journal-title":"Front. Immunol."},{"key":"73617_CR79","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1158\/1538-7445.AM2019-3202","volume":"79","author":"EL Scolan","year":"2019","unstructured":"Scolan, E. L. et al. A probody drug conjugate targeting CD166 (ALCAM) enhances preclinical antitumor activity of a probody therapeutic targeting PD-1. Cancer Res. 79, 3202\u20133202 (2019).","journal-title":"Cancer Res."},{"key":"73617_CR80","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.3390\/cancers13205187","volume":"13","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. The clinical and theranostic values of activated leukocyte cell adhesion molecule (ALCAM)\/CD166 in human solid cancers. Cancers 13, 5187 (2021).","journal-title":"Cancers"},{"key":"73617_CR81","doi-asserted-by":"crossref","unstructured":"Launonen, I.-M. et al. Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer. Cancer Cell 42, 2045\u20132063 (2024).","DOI":"10.1016\/j.ccell.2024.11.005"},{"key":"73617_CR82","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","volume":"25","author":"CH Ries","year":"2014","unstructured":"Ries, C. H. et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 25, 846\u2013859 (2014).","journal-title":"Cancer Cell"},{"key":"73617_CR83","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s40265-019-01210-0","volume":"79","author":"YN Lamb","year":"2019","unstructured":"Lamb, Y. N. Pexidartinib: first approval. Drugs 79, 1805\u20131812 (2019).","journal-title":"Drugs"},{"key":"73617_CR84","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1158\/1078-0432.CCR-20-3955","volume":"28","author":"S Kuemmel","year":"2022","unstructured":"Kuemmel, S. et al. A randomized phase II study of anti-CSF1 monoclonal antibody lacnotuzumab (mcs110) combined with gemcitabine and carboplatin in advanced triple-negative breast cancer. Clin. Cancer Res. 28, 106\u2013115 (2022).","journal-title":"Clin. Cancer Res."},{"key":"73617_CR85","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1158\/1538-7445.AM2023-2328","volume":"83","author":"ME Fernandez","year":"2023","unstructured":"Fernandez, M. E. et al. Macrophage-targeting immunotherapy for triple negative breast cancer. Cancer Res. 83, 2328\u20132328 (2023).","journal-title":"Cancer Res."},{"key":"73617_CR86","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1111\/cas.15751","volume":"114","author":"Y Komohara","year":"2023","unstructured":"Komohara, Y. et al. Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes. Cancer Sci. 114, 2220 (2023).","journal-title":"Cancer Sci."},{"key":"73617_CR87","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"73617_CR88","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","volume":"6","author":"Z Duan","year":"2021","unstructured":"Duan, Z. & Luo, Y. Targeting macrophages in cancer immunotherapy. Signal Transduct. Target. Ther. 6, 127 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"73617_CR89","doi-asserted-by":"publisher","first-page":"1199631","DOI":"10.3389\/fimmu.2023.1199631","volume":"14","author":"S Xu","year":"2023","unstructured":"Xu, S. et al. Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy. Front. Immunol. 14, 1199631 (2023).","journal-title":"Front. Immunol."},{"key":"73617_CR90","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1182\/bloodadvances.2021005141","volume":"5","author":"Y-H Wang","year":"2021","unstructured":"Wang, Y.-H. et al. A Cibersortx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes. Blood Adv. 5, 4535\u20134548 (2021).","journal-title":"Blood Adv."},{"key":"73617_CR91","doi-asserted-by":"crossref","unstructured":"Shahrouzi, P. et al. Loss of chromosome cytoband 13q14. 2 orchestrates breast cancer pathogenesis and drug response. Breast Cancer Res. 26, 170 (2024).","DOI":"10.1186\/s13058-024-01924-4"},{"key":"73617_CR92","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"73617_CR93","unstructured":"Therneau, T. M. A package for survival analysis in R https:\/\/CRAN.R-project.org\/package=survival (2024)."},{"key":"73617_CR94","doi-asserted-by":"publisher","first-page":"106484","DOI":"10.1016\/j.isci.2023.106484","volume":"26","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. Prioritizing exhausted T cell marker genes highlights immune subtypes in pan-cancer. Iscience 26, 106484 (2023).","journal-title":"Iscience"},{"key":"73617_CR95","doi-asserted-by":"publisher","unstructured":"Azimzade, Y., Haugen, M. H., Kristensen, V. N., Frigessi, A. & K\u00f6hn-Luque, A. Code for: Survival-xml-tme-bc https:\/\/doi.org\/10.5281\/zenodo.18836407 (2026).","DOI":"10.5281\/zenodo.18836407"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73617-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73617-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73617-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:02:24Z","timestamp":1784854944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73617-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73617"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73617-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7193"}}